Agree. FDA wont just say yep, lets go ahead. The current testing sample size is very small. They will ask for more testing for sure imo. But im comfortable if this is the only barrier and then its just assessing the timeline with more testing. The risk is the unknown or if FDA are more negative.
- Forums
- ASX - By Stock
- LTP
- Ann: Appendix 4D and Half Yearly Report
LTP
ltr pharma limited
Add to My Watchlist
3.45%
!
30.0¢

Ann: Appendix 4D and Half Yearly Report, page-253
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $33.58M |
Open | High | Low | Value | Volume |
29.0¢ | 30.0¢ | 28.5¢ | $105.7K | 362.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 407 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.290 |
1 | 24000 | 0.285 |
2 | 230000 | 0.280 |
5 | 137909 | 0.275 |
10 | 192157 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 9760 | 1 |
0.310 | 3286 | 1 |
0.315 | 9460 | 1 |
0.320 | 4762 | 2 |
0.325 | 79383 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online